Atlas Trials

Antineoplastic Agents, Hormonal

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Antineoplastic Agents, Hormonal

RecordFirmDate
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (NCT05288166)Eli Lilly and Company2022-04-14

Track Antineoplastic Agents, Hormonal automatically

Every clearance here is in the API, with alerts when new ones post.